Home > Healthcare > Pharmaceuticals > Finished Drug Form > Retinal Disorder Treatment Market
Retinal Disorder Treatment Market Size
- Report ID: GMI10121
- Published Date: Jul 2024
- Report Format: PDF
Retinal Disorder Treatment Market Size
Retinal Disorder Treatment Market size was valued at around USD 13.7 billion in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032. Retinal disorder treatment encompasses the medical and surgical interventions used to diagnose, manage, and treat various conditions affecting the retina, the light-sensitive layer at the back of the eye essential for vision. The primary goal of these treatments is to preserve or restore vision, prevent further vision loss, and improve the quality of life for patients suffering from retinal disorders.
The rising incidence of diabetes is a significant driver for the market. For instance, according to World Health Organization (WHO), in 2021 reported that 537 million adults aged 20-79 are affected by diabetes, equating to approximately one in ten adults. Projections indicate that this figure could increase to 643 million by 2030 and 783 million by 2045. Therefore, this underscores the critical need for advancements in the retinal disorder treatment to address the growing prevalence of diabetes-related eye complications. Furthermore, rising geriatric population base, technological advancements, and rising awareness and screening programs, are driving factors for the market growth.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Retinal Disorder Treatment Market Size in 2023: | USD 13.7 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 9.6% |
| 2032 Value Projection: | USD 31.1 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 175 |
| Tables, Charts & Figures: | 227 |
| Segments covered: | Type, Dosage Form, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Retinal Disorder Treatment Market Scope
